Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Triazolyl aminocyclitol derivatives acting as chaperones of the glucocerebrosidase enzyme, restoring its activity at micro and nanomolar concentrations. These compounds may have application as drugs in the treatment of Gaucher disease More
New aminocyclitol derivatives acting as chaperones of the mutated glucocerebrosidase enzyme, restoring its activity at nM and sub-nM concentrations. These compounds may have application as drugs to treat Gaucher disease, including the lethal type II More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 83 pages - $1,495
Jun 2011 - 44 pages - $1,000
Nov 2010 - 50 pages - $500
May 2011 - 64 pages - $500
Feb 2011 - 42 pages - $5,700
Mar 2011 - 174 pages - $4,795
Mar 2011 - 56 pages - $250
Nov 2010 - 933 pages - $1,495
Nov 2010 - 308 pages - $1,495
Mar 2011 - 42 pages - $5,700
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us